|
PPP1CB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.362000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.702460E-03 |
| Normal-vs-Stage2 |
6.519000E-01 |
| Normal-vs-Stage3 |
1.734270E-02 |
| Normal-vs-Stage4 |
3.108000E-02 |
| Stage1-vs-Stage2 |
4.736100E-02 |
| Stage1-vs-Stage3 |
7.168200E-01 |
| Stage1-vs-Stage4 |
9.680600E-01 |
| Stage2-vs-Stage3 |
1.113830E-01 |
| Stage2-vs-Stage4 |
1.017030E-01 |
| Stage3-vs-Stage4 |
7.787000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.303800E-03 |
| Normal-vs-AfricanAmerican |
1.567570E-02 |
| Normal-vs-Asian |
1.879030E-01 |
| Caucasian-vs-AfricanAmerican |
5.549800E-01 |
| Caucasian-vs-Asian |
3.285600E-01 |
| AfricanAmerican-vs-Asian |
2.064400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.802230E-02 |
| Normal-vs-Female |
2.437500E-03 |
| Male-vs-Female |
7.652200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.445600E-04 |
| Normal-vs-Age(41-60Yrs) |
5.530200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.512400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.391900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.895610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.499500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.885200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.474600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.151000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.444600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.161600E-02 |
| Classical-VS-Follicular |
6.163400E-03 |
| Classical-VS-Other |
6.901800E-01 |
| Classical-VS-Normal |
4.988600E-04 |
| Tall-VS-Follicular |
1.796480E-03 |
| Tall-VS-Other |
2.370000E-01 |
| Tall-VS-Normal |
6.802400E-04 |
| Follicular-VS-Other |
6.024800E-01 |
| Follicular-VS-Normal |
4.889800E-01 |
| Other-VS-Normal |
3.230800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.986620E-01 |
| Normal-vs-N1 |
4.285900E-02 |
| N0-vs-N1 |
1.701760E-01 |
|
|
